Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: analysis of BMT CTN-0201 and -0901 samples.

TitleRecipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: analysis of BMT CTN-0201 and -0901 samples.
Publication TypeJournal Article
Year of Publication2018
AuthorsRashidi, A, Shanley, R, Yohe, SL, Thyagarajan, B, Curtsinger, J, Anasetti, C, Waller, EK, Scott, BL, Blazar, BR, Weisdorf, DJ
JournalBr J Haematol
Volume182
Issue6
Pagination887-894
Date Published2018 09
ISSN1365-2141
KeywordsAcute Disease, alpha-Defensins, Antimicrobial Cationic Peptides, Blood Specimen Collection, Bone Marrow Transplantation, Clinical Trials as Topic, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Host Microbial Interactions, Humans, Microbiota, Pancreatitis-Associated Proteins, Paneth Cells, Polymorphism, Single Nucleotide, Prognosis
Abstract

Host genetics shape the gut microbiota, and gut dysbiosis increases the risk of acute graft-versus-host disease (aGVHD). Paneth cells and microbiota have interactions that contribute to immune regulation. α-defensin-5 (HD5) and regenerating islet-derived protein 3 alpha (Reg3A) are the most abundant Paneth cell antimicrobial peptides (AMPs). We hypothesized that single nucleotide polymorphisms (SNPs) in the genes for HD5 (DEFA5) and Reg3A (REG3A) predict aGVHD risk. We analysed pre-transplant recipient peripheral blood mononuclear cell samples from randomized Blood and Marrow Transplant Clinical Trials Network (BMT CTN) studies 0201 (94 patients with bone marrow and 93 with peripheral blood grafts) and 0901 (86 patients with myeloablative and 77 with reduced-intensity conditioning; all using peripheral blood grafts). In multivariable analysis (with a SNP × graft source interaction term in CTN-0201 and a SNP × conditioning intensity term in CTN-0901), DEFA5 rs4415345 and rs4610776 were associated with altered incidence of aGVHD grade II-IV [rs4415345 G vs. C: hazard ratio (HR) 0·58, 95% confidence interval (95% CI) 0·37-0·92, P = 0·02; rs4610776 T vs. A: HR 1·53, 95% CI 1·01-2·32, P = 0·05] in CTN-0201, but not CTN-0901, suggesting a stronger effect in bone marrow allografts. REG3A SNP was not associated with aGVHD. Host genetics may influence aGVHD risk by modulating Paneth cell function.

DOI10.1111/bjh.15492
Alternate JournalBr J Haematol
PubMed ID30004111
PubMed Central IDPMC6128755
Grant ListU10 HL069294 / HL / NHLBI NIH HHS / United States
P30 CA077598 / CA / NCI NIH HHS / United States
P01 CA065493 / CA / NCI NIH HHS / United States
UL1 TR000114 / TR / NCATS NIH HHS / United States
R37 AI034495 / AI / NIAID NIH HHS / United States
UG1 HL109137 / HL / NHLBI NIH HHS / United States
UG1 HL069301 / HL / NHLBI NIH HHS / United States
UG1 HL069290 / HL / NHLBI NIH HHS / United States
U24 CA076518 / CA / NCI NIH HHS / United States
U24 HL138660 / HL / NHLBI NIH HHS / United States